Suvorexant
Schedule IVThe first of the class, approved in 2014. Its half-life of roughly 12 hours is why the label keeps the ceiling at 20 mg and warns about driving the next day at that dose.
- Indication
- Insomnia: trouble falling or staying asleep
- Label start dose
- 10 mg
- Timing
- Within 30 min of bed, at least 7 h left
- Maximum
- 20 mg once nightly
- Not for narcolepsy. Sleep paralysis and dream-like hallucinations at sleep onset are listed reactions.
- Strong CYP3A inhibitors such as clarithromycin or ketoconazole: not recommended. Moderate inhibitors: 5 mg.
- Taking it with or soon after a meal delays the effect.
- At 20 mg, next-day driving was impaired in label studies. Start at 10.
Source · FDA label · Section 2 Dosage · Section 5.1